Immunosuppressive Medication HCPCS
activeURL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.82Copied!
Version20220315Copied!
PublisherCMS DRLS StewardDate2022-03-15T01:04:14-04:00Purpose(Clinical Focus: Immunosuppressive medications including dose and route of administration.),(Data Element Scope: Immunosuppressive medications, dose and route of administration that are reported to the US Centers for Medicare and Medicaid using J codes from the Healthcare Common Procedure Coding System (HCPCS) code system.),(Inclusion Criteria: Immunosuppressive medications, route of administration and dose that are reported to the US Centers for Medicare and Medicaid.),(Exclusion Criteria: Immunosuppressive medications, route of administration and dose that are not reported to the US Centers for Medicare and Medicaid.)
Expansion
Expansion error
Can't resolve code system: http://www.nlm.nih.gov/research/umls/hcpcs
systemhttp://www.nlm.nih.gov/research/umls/hcpcs
{
"compose" : {
"exclude" : [ ],
"include" : [ {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"extension" : [ {
"extension" : [ {
"valueString" : "concept",
"url" : "path"
}, {
"url" : "count",
"valueInteger" : 17
} ],
"url" : "http://health-samurai.io/extensions/excised-data"
} ]
} ]
},
"date" : "2022-03-15T01:04:14-04:00",
"meta" : {
"versionId" : "9",
"lastUpdated" : "2022-03-15T01:04:14.000-04:00",
"profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
},
"publisher" : "CMS DRLS Steward",
"jurisdiction" : [ {
"extension" : [ {
"valueString" : "UNKNOWN",
"url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason"
} ]
} ],
"purpose" : "(Clinical Focus: Immunosuppressive medications including dose and route of administration.),(Data Element Scope: Immunosuppressive medications, dose and route of administration that are reported to the US Centers for Medicare and Medicaid using J codes from the Healthcare Common Procedure Coding System (HCPCS) code system.),(Inclusion Criteria: Immunosuppressive medications, route of administration and dose that are reported to the US Centers for Medicare and Medicaid.),(Exclusion Criteria: Immunosuppressive medications, route of administration and dose that are not reported to the US Centers for Medicare and Medicaid.)",
"name" : "ImmunosuppressiveMedicationHCPCS",
"experimental" : false,
"resourceType" : "ValueSet",
"expansion" : {
"contains" : [ {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "J0485",
"display" : "Injection, belatacept, 1 mg",
"version" : "2023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "J7500",
"display" : "Azathioprine, oral, 50 mg",
"version" : "2023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "J7501",
"display" : "Azathioprine, parenteral, 100 mg",
"version" : "2023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "J7503",
"display" : "Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg",
"version" : "2023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "J7504",
"display" : "Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg",
"version" : "2023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "J7505",
"display" : "Muromonab-cd3, parenteral, 5 mg",
"version" : "2023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "J7507",
"display" : "Tacrolimus, immediate release, oral, 1 mg",
"version" : "2023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "J7508",
"display" : "Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg",
"version" : "2023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "J7511",
"display" : "Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg",
"version" : "2023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "J7513",
"display" : "Daclizumab, parenteral, 25 mg",
"version" : "2023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "J7517",
"display" : "Mycophenolate mofetil, oral, 250 mg",
"version" : "2023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "J7518",
"display" : "Mycophenolic acid, oral, 180 mg",
"version" : "2023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "J7520",
"display" : "Sirolimus, oral, 1 mg",
"version" : "2023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "J7525",
"display" : "Tacrolimus, parenteral, 5 mg",
"version" : "2023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "J7527",
"display" : "Everolimus, oral, 0.25 mg",
"version" : "2023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "J7599",
"display" : "Immunosuppressive drug, not otherwise classified",
"version" : "2023"
}, {
"system" : "http://www.nlm.nih.gov/research/umls/hcpcs",
"code" : "J8610",
"display" : "Methotrexate; oral, 2.5 mg",
"version" : "2023"
} ],
"offset" : 0,
"total" : 17,
"identifier" : "urn:uuid:a602be51-d42b-460f-ada2-eafda9e24e20",
"timestamp" : "2023-06-29T17:58:17-04:00",
"parameter" : [ {
"name" : "count",
"valueInteger" : 1000
}, {
"name" : "offset",
"valueInteger" : 0
} ]
},
"title" : "Immunosuppressive Medication HCPCS",
"extension" : [ {
"valueString" : "CMS DRLS Author",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
}, {
"valueDate" : "2022-12-15",
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
}, {
"valueDate" : "2022-03-15",
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
}, {
"url" : "http://health-samurai.io/extensions/source",
"valueCode" : "db"
} ],
"status" : "active",
"id" : "28c10ce5-cf1f-42bf-b83d-0ea0eac3b395",
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1219.82",
"identifier" : [ {
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1219.82"
} ],
"version" : "20220315"
}